Breast cancer in men

Annals of Internal Medicine

Volumn 137, Issue 8, 2002, Pages 678-687

  Giordano, Sharon H ^a   Buzdar, Aman U ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANDROGEN; ANTHRACYCLINE; ANTIANDROGEN; BRCA2 PROTEIN; CYCLIN D1; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FLUOROURACIL; GONADORELIN AGONIST; METHOTREXATE; PROGESTERONE DERIVATIVE; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53; STEROID; TAMOXIFEN;

AGE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER SUSCEPTIBILITY; DISEASE MARKER; DRUG INDUCED DISEASE; FAMILY HISTORY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; JEW; KLINEFELTER SYNDROME; LYMPH NODE; MALE; MASTECTOMY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TESTIS DISEASE; TUMOR VOLUME; UNITED STATES;

EID: 0037108651     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-8-200210150-00013     Document Type: Review

References (114)

1. Jaiyesimi IA, Buzdar AU, Sahin AA, Ross MA. Carcinoma of the male breast. Ann Intern Med. 1992;117:771-7. [PMID: 1416579]
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47. [PMID: 11814064]
3. La Vecchia C, Levi F, Lucchini F. Descriptive epidemiology of male breast cancer in Europe. Int J Cancer. 1992;51:62-6. [PMID: 1563846]
4. Crichlow RW. Carcinoma of the male breast. Surg Gynecol Obstet. 1972;134:1011-9. [PMID: 4338101]
5. Ewertz M, Holmberg L, Karjalainen S, Tretli S, Adami HO. Incidence of male breast cancer in Scandinavia, 1943-1982. Int J Cancer. 1989;43:27-31. [PMID: 2910829]
6. Amir H, Makwaya CK, Moshiro C, Kwesigabo G. Carcinoma of the male breast: a sexually transmitted disease? East Afr Med J. 1996;73:187-90. [PMID: 8698019]
7. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:538-49. [PMID: 8436428]
8. Surveillance, Epidemiology, and End Results (SEER) Program. Public-Use Data (1993-1997). Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; April 2000.
9. Thomas DB, Jimenez LM, McTieman A, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135:734-48. [PMID: 1350708]
10. Hultborn R, Hanson C, Köpfl, Verbiené I, Warnhammar E, Weimarck A. Prevalence of Klinefelter's syndrome in male breast cancer patients. Anticancer Res. 1997;17:4293-7. [PMID: 9494523]
11. van Geel AN, van Slooten EA, Mavrunac M, Hart AA. A retrospective study of male breast cancer in Holland. Br J Surg. 1985;72:724-7. [PMID: 2994794]
12. Hsing AW, McLaughlin JK, Cocco P, Co Chien HT, Fraumeni JF Jr. Risk factors for male breast cancer (United States). Cancer Causes Control. 1998;9:269-75. [PMID: 9684707]
13. Sørensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al. Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol. 1998;93:231-3. [PMID: 9468249]
14. Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst. 1991;83:849-54. [PMID: 2061945]
15. Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629-39. [PMID: 10091736]
16. Yildírím E, Berberoǧlu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol. 1998;24:548-52. [PMID: 9870732]
17. Braunstein GD. Gynecomastia. N Engl J Med. 1993;328:490-5. [PMID: 8421478]
18. Williams MJ. Gynecomastia. Am J Med. 1963;34:103-12.
19. Cutuli B, Lacroze M, Dilhuydy JM, Velten M, De Lafontan B, Marchal C, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31A:1960-4. [PMID: 8562148]
20. Hill A, Yagmur Y, Tran KN, Bolton JS, Robson M, Borgen PI. Localized male breast carcinoma and family history. An analysis of 142 patients. Cancer. 1999;86:821-5. [PMID: 10463981]
21. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet. 1997;60:313-9. [PMID: 9012404]
22. Salvadori B, Saccozzi R, Manzari A, Andreola S, Conti RA, Cusumano F, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer. 1994;30A:930-5. [PMID: 7946586]
23. Struewing JP, Brody LC, Erdos MR, Kase RG, Giambarresi TR, Smith SA, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet. 1995;57:1-7. [PMID: 7611277]
24. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994;265:2088-90. [PMID: 8091231]
25. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676-89. [PMID: 9497246]
26. Osorio A, Barroso A, Martínez B, Cebrián A, San Román JM, Lobo F, et al. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer. 2000;82:1266-70. [PMID: 10755399]
27. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet. 1996;13:123-5. [PMID: 8673091]
28. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet. 1996;13:117-9. [PMID: 8673089]
29. Mavraki E, Gray IC, Bishop DT, Spurr NK. Germline BRCA2 mutations in men with breast cancer. Br J Cancer. 1997;76:1428-31. [PMID: 9400938]
30. Haraldsson K, Loman N, Zhang QX, Johannsson O, Olsson H, Borg A. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history ofthe disease. Cancer Res. 1998;58:1367-71. [PMID: 9537231]
31. Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, et al. High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res. 1999;59:995-8. [PMID: 10070953]
32. Díez O, Cortés J, Domènech M, Pericay C, Brunet J, Alonso C, et al. BRCA2 germ-line mutations in Spanish male breast cancer patients. Ann Oncol. 2000;11:81-4. [PMID: 10690392]
33. Hakansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet. 1997;60:1068-78. [PMID: 9150154]
34. Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stemhagen A, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control. 1993;4:143-51. [PMID: 8386948]
35. Sanchez AG, Villanueva AG, Redondo C. Lobular carcinoma of the breast in a patient with Klinefelter's syndrome. A case with bilateral, synchronous, histologically different breast tumors. Cancer. 1986;57:1181-3. [PMID: 3002597]
36. McLachlan SA, Erlichman C, Liu FF, Miller N, Pintilie M. Male breast cancer: an 11 year review of 66 patients. Breast Cancer Res Treat. 1996;40:225-30. [PMID: 8883964]
37. Hittmair AP, Lininger RA, Tavassoli FA. Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma-a preliminary report. Cancer. 1998;83:2139-49. [PMID: 9827718]
38. Heller KS, Rosen PP, Schottenfeld D, Ashikari R, Kinne DW. Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg. 1978;188:60-5. [PMID: 208472]
39. Ramantanis G, Besbeas S, Garas JG. Breast cancer in the male: a report of 138 cases. World J Surg. 1980;4:621-3. [PMID: 7233931]
40. Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13-year review of 89 patients. J Clin Oncol. 1984;2:903-9. [PMID: 6086848]
41. Ourìel K, Lotze MT, Hinshaw JR. Prognostic factors of carcinoma of the male breast. Surg Gynecol Obstet. 1984;159:373-6. [PMID: 6484794]
42. Izquierdo MA, Alonso C, De Andres L, Ojeda B. Male breast cancer. Report of a series of 50 cases. Acta Oncol. 1994;33:767-71. [PMID: 7993644]
43. Ribeiro G, Swindell R, Harris M, Banerjee S, Cramer A. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. The Breast. 1996;5:141-6.
44. Stierer M, Rosen H, Weitensfelder W, Hausmaninger H, Teleky B, Jakesz R, et al. Male breast cancer: Austrian experience. World J Surg. 1995;19:687-92; discussion 692-3. [PMID: 7571664]
45. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83:498-509. [PMID: 9690543]
46. Holleb AI, Freeman HP, Farrow JH. Cancer of male breast. II. N Y State J Med. 1968;68:656-63. [PMID: 4171099]
47. Norris HJ, Taylor HB. Carcinoma of the male breast. Cancer. 1969;23:1428-35. [PMID; 5771071]
48. Wick MR, Sayadi H, Ritter JH, Hill DA, Reddy VB, Gattuso P. Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma. Am J Clin Pathol. 1999;111:59-69. [PMID: 9894455]
49. Willsher PC, Leach IH, Ellis IO, Bourke JB, Blamey RW, Robertson JF. A comparison outcome of male breast cancer with female breast cancer. Am J Surg. 1997;173:185-8. [PMID: 9124623]
50. Dawson PJ, Paine TM, Wolman SR. Immunocytochemical characterization of male breast cancer. Mod Pathol. 1992;5:621-5. [PMID: 1369797]
51. Everson RB, Lippman ME, Thompson EB, McGuire WL, Wittliff JL, De Sombre ER, et al. Clinical correlations of steroid receptors and male breast cancer. Cancer Res. 1980;40:991-7. [PMID: 7357565]
52. Muñoz de Toro MM, Maffini MV, Kass L, Luque EH. Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Biol. 1998;67:333-9. [PMID: 9883990]
53. Tan PH, Sng IT. Male breast cancer: a retrospective study with immunohistochemical analysis of hormone receptor expression. Pathology. 1997;29:2-6. [PMID: 9094169]
54. Sasano H, Kimura M, Shizawa S, Kimura N, Nagura H. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metab. 1996;81:3063-7. [PMID: 8768875]
55. Pich A, Margaria E, Chiusa L, Ponti R, Geuna M. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. Hum Pathol. 1996;27:676-82. [PMID: 8698311]
56. Hiort O, Naber SP, Lehners A, Muletta-Feurer S, Sinnecker GH, Zöllner A, et al. The role of androgen receptor gene mutations in male breast carcinoma. J Clin Endocrinol Metab. 1996;81:3404-7. [PMID: 8784104]
57. Anelli A, Anelli TF, Youngson B, Rosen PP, Borgen PI. Mutations of the p53 gene in male breast cancer. Cancer. 1995;75:2233-8. [PMID: 7712430]
58. Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490-8. [PMID: 8630956]
59. Willsher PC, Leach IH, Ellis IO, Bell JA, Elston CW, Bourke JB, et al. Male breast cancer: pathological and immunohistochemical features. Anticancer Res. 1997;17:2335-8. [PMID: 9245247]
60. Weber-Chappuis K, Bieri-Burger S, Hurlimann J. Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur J Cancer. 1996;32A:1686-92. [PMID: 8983275]
61. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, et al. Molecular markers in male breast carcinoma. Cancer. 1998;83:1947-55. [PMID: 9806653]
62. Ribeiro GG. Tamoxifen in the treatment of male breast carcinoma. Clin Radiol. 1983;34:625-8. [PMID: 6673881]
63. Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer. 1992;65:252-4. [PMID: 1739625]
64. Borgen PI, Wong GY, Vlamis V, Potter C, Hoffmann B, Kinne DW, et al. Current management of male breast cancer. A review of 104 cases. Ann Surg. 1992;215:451-7; discussion 457-9. [PMID: 1319699]
65. Borgen PI, Senie RT, McKinnon WM, Rosen PP. Carcinoma of the male breast: analysis of prognosis compared with matched female patients. Ann Surg Oncol. 1997;4:385-8. [PMID: 9259964]
66. Williams WL Jr, Powers M, Wagman LD. Cancer of the male breast: a review. J Nad Med Assoc. 1996;88:439-43. [PMID: 8764526]
67. Carmalt HL, Mann LJ, Kennedy CW, Fletcher JM, Gillett DJ. Carcinoma of the male breast: a review and recommendations for management. Aust N Z J Surg. 1998;68:712-5. [PMID: 9768607]
68. Sandler B, Carman C, Perry RR. Cancer of the male breast. Am Surg. 1994;60:816-20. [PMID: 7978672]
69. Bagley CS, Wesley MN, Young RC, Lippman ME. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol. 1987;10:55-60. [PMID: 3825994]
70. Patel HZ 2nd, Buzdar AU, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer. 1989;64:1583-5. [PMID: 2676137]
71. Digenis AG, Ross CB, Morrison JG, Holcomb GW 3rd, Reynolds VH. Carcinoma of the male breast: a review of 41 cases. South Med J. 1990;83:1162-7. [PMID: 1699287]
72. Morimoto T, Komaki K, Yamakawa T, Tanaka T, Oomine Y, Konishi Y, et al. Cancer of the male breast. J Surg Oncol. 1990;44:180-4. [PMID: 2370802]
73. Clark JL, Nguyen PL, Jaszcz WB, Jatoi A, Niehans GA. Prognostic variables in male breast cancer. Am Surg. 2000;66:502-11. [PMID: 10824754]
74. Gupta N, Cohen JL, Rosenbaum C, Raam S. Estrogen receptors in male breast cancer. Cancer. 1980;46:1781-4. [PMID: 7427879]
75. Fox SB, Rogers S, Day CA, Underwood JC. Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma. J Pathol. 1992;166:13-8. [PMID: 1538271]
76. Bruce DM, Heys SD, Payne S, Miller ID, Eremin O. Male breast cancer: clinico-pathological features, immunocytochemical characteristics and prognosis. Eur J Surg Oncol. 1996;22:42-6. [PMID: 8846866]
77. Dawson PJ, Schroer KR, Wolman SR. ras and p53 genes in male breast cancer. Mod Pathol. 1996;9:367-70. [PMID: 8729973]
78. Friedman MA, Hoffman PG Jr, Dandolos EM, Lagios MD, Johnston WH, Siiteri PK. Estrogen receptors in male breast cancer: clinical and pachologic correlations. Cancer. 1981;47:134-7. [PMID: 6257370]
79. Gattuso P, Reddy VB, Green LK, Castelli MJ, Wick MR. Prognostic factors for carcinoma of the male breast. International Journal of Surgical Pathology. 1995;2:199-206.
80. Kraybill WG, Kaufman R, Kinne D. Treatment of advanced male breast cancer. Cancer. 1981;47:2185-9. [PMID: 6164479]
81. McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, et al. Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. Bone Marrow Transplant. 1999;24:365-8. [PMID: 10467324]
82. Bezwoda WR, Hesdorffer C, Dansey R, de Moor N, Derman DP, Browde S, et al. Breast cancer in men. Clinical features, hormone receptor status, and response to therapy. Cancer. 1987;60:1337-40. [PMID: 3621116]
83. Pich A, Margaria E, Chiusa L. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival. J Clin Oncol. 2000;18:2948-56. [PMID: 10944127]
84. Fox SB, Day CA, Rogers S. Lack of c-erbB-2 oncoprotein expression in male breast carcinoma. J Clin Pathol. 1991;44:960-1. [PMID: 1684366]
85. Leach IH, Ellis IO, Elston CW. c-erb-B-2 expression in male breast carcinoma [Letter]. J Clin Pathol. 1992;45:942. [PMID: 1430274]
86. Blin N, Kardás, Welter C, Ryś J, Niezabitowski A, Limon J, et al. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Oncology. 1993;50:408-11. [PMID: 7901823]
87. Bines J, Goss B, Hussong J, Chmiel J, Yelandi AV, Gradisher WJ. C-erbB2 and p53 overexpression as predictors of survival in patients with male breast cancer (Abstract). Proceedings of ASCO. 1997;16:558.
88. Bloom K, Reddy V, Green L, Gattuso P. Male breast carcinomas do not show amplification of the her-2/neu gene [Abstract]. Breast Cancer Res Treat. 2000;64:127.
89. Hecht JR, Winchester DJ. Male breast cancer. Am J Clin Pathol. 1994;102:S25-30. [PMID: 7942610]
90. Mies C, Mejias A, Nadji M, Morales A. P53 and her-2/neu are rarely immunohistochemically detected in male breast cancer [Abstract]. Lab Invest. 1994;70:19A.
91. Moore J, Friedman M, Gramlich T, Gansler T, DeRose P, Cohen C. Prognostic indicators in male breast cancer [Abstract]. Lab Invest. 1994;70:19A.
92. Wieczorek R, Heller P, Feiner H, Sidhu G, Demopoulos R, Jagirdar J, et al. P53 protein overexpression in male breast cancer: clinicopathologic correlation [Abstract]. Lab Invest. 1994;70:24A.
93. Pich A, Margaria E, Chiusa L. Bcl-2 expression in male breast carcinoma. Virchows Arch. 1998;433:229-35. [PMID: 9769126]
94. Arber N, Hibshoosh H, Zhang Y, Han E, Sgambato A, Weinstein I. Overexpression of cyclin D1 in both female and male breast cancers [Abstract]. Proc Annu Meet Am Assoc Cancer Res. 1995;36:A1350.
95. Dickerson R, Lippman ME. Pathogenesis of breast cancer. In: Harris J, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:281-302.
96. Clark G. Prognostic and predictive factors. In: Harris JR, ed. Diseases of the Breast. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:489-514.
97. Joensuu H, Pylkkänen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol. 1994;145:1191-8. [PMID: 7977649]
98. Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW, Peter Z, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer. 1993;71:154-61. [PMID: 8416712]
99. Rudan I, Rudan N, Basič N, Basič V, Rudan D, Jambrisak Z. Differences between male and female breast cancer. III. Prognostic features. Acta Med Croatica. 1997;51:135-41. [PMID: 9248110]
100. Scheike O. Male breast cancer. 6. Factors influencing prognosis. Br J Cancer. 1974;30:261-71. [PMID: 4451631]
101. Adami HO, Holmberg L, Malker B, Ries L. Long-term survival in 406 males with breast cancer. Br J Cancer. 1985;52:99-103. [PMID: 4015955]
102. Ribeiro G. Male breast carcinoma-a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester. Br J Cancer. 1985;51:115-9. [PMID: 3966965]
103. Ribeiro GG. Carcinoma of the male breast: a review of 200 cases. Br J Surg. 1977;64:381-3. [PMID: 68794]
104. Spence RA, MacKenzie G, Anderson JR, Lyons AR, Bell M. Long-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases. Cancer. 1985;55:648-52. [PMID: 3965113]
105. Yap HY, Tashima CK, Blumenschein GR, Eckles NE. Male breast cancer: a natural history study. Cancer. 1979;44:748-54. [PMID: 476581]
106. Ciatto S, Iossa A, Bonardi R, Pacini P. Male breast carcinoma: review of a multicenter series of 150 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Tumori. 1990;76:555-8. [PMID: 2284691]
107. Scheike O. Male breast cancer. 5. Clinical manifestations in 257 cases in Denmark. Br J Cancer. 1973;28:552-61. [PMID: 4783156]
108. Joshi A, Kapila K, Verma K. Fine needle aspiration cytology in the management of male breast masses. Nineteen years of experience. Acta Cytol. 1999;43:334-8. [PMID: 10349358]
109. Fleming ID, Cooper JS, Henson DE, Hutter RV, Kennedy BJ, Murphy GP, et al. AJCC Cancer Staging Manual/American Joint Committee on Cancer. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 1997.
110. Gough DB, Donohue JH, Evans MM, Pernicone PJ, Wold LE, Naessens JM, et al. A 50-year experience of male breast cancer: is outcome changing? Surg Oncol. 1993;2:325-33. [PMID: 8130939]
111. Robison R, Montague ED. Treatment results in males with breast cancer. Cancer. 1982;49:403-6. [PMID: 7053837]
112. Farrow J, Adair FE. Effect of orchiectomy on skeletal metastases from cancer of the male breast. Science. 1942;95:654.
113. Kantarjian H, Yap HY, Hortobagyi G, Buzdar A, Blumenschein G. Hormonal therapy for metastatic male breast cancer. Arch Intern Med. 1983;143:237-40. [PMID: 6824391]
114. Lopez M, Di Lauro L, Lazzaro B, Papaldo P. Hormonal treatment of disseminated male breast cancer. Oncology. 1985;42:345-9. [PMID: 2933617]